Adiuvo Investments S.A.

Other financial service activities, except insurance and pension funding not elsewhere

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-08-24
Share capital
1,317,434.60 PLN
Activity description

Adiuvo Investments invests in MedTech companies, combining capital with hands-on operational support and strategic guidance. It backs technologies in areas including aesthetic and post-mastectomy reconstruction, oncology medicine, and remote cardiac monitoring, helping companies progress through clinical, regulatory, and commercial milestones.

Registered address
ul. Szara 10, 00-420 Warszawa, Poland
Email
Electronic delivery address
AE:PL-50780-54832-DSGIC-13

Financials

Revenue history (in m)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 105 days for 2023). All were audited by a statutory auditor.

  • 2025not filed
  • 202408/10/2025
  • 202328/10/2024
  • 202217/07/2023
  • 202104/07/2022
  • 202009/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.55
0.00 (0.00%)
0.540.540.540.550.5510:0012:0014:0016:00
Open
PLN 0.54
High
PLN 0.55
Low
PLN 0.54
Volume
21.73K
Avg. vol.
30.39K
Market cap
PLN 88.86M
P/E ratio
–
EPS
-PLN 0.02
Shares outstanding
162.75M
52-week
PLN 0.54 – 0.59
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 152.89kUSD -53.48kUSD -215.02k
Q1 2026USD 12.43kUSD -246.62kUSD -376.82k
Q4 2025USD -27.12kUSD 10.30kUSD -79.36k
Q3 2025USD 85.89kUSD -220.74kUSD -298.34k

Results for Q3 2026:Nov 30, 2026

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 4.5%
Sector · Real estate activities864 / 8,932
Top 9.7%
Voivodeship · Mazowieckie12,114 / 142,204
Top 8.5%
Country · Poland42,665 / 496,474
Top 8.6%

Results vs industry

Revenue
This companyUSD 5.16mMedianUSD 77.17kAverageUSD 1.58m
Net profit
This companyUSD -773.49kMedianUSD 1.91kAverageUSD 202.79k
Operating costs
This companyUSD 523.18kMedianUSD 43.34kAverageUSD 952.74k
Assets
This companyUSD 101.73kMedianUSD 197.01kAverageUSD 10.26m

Offer

Websites

  • adiuvo.meAdiuvo Investments – Seed Capital for MedTech Companies
    Apache

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. 10 marks have expired or were not registered. The first mark was filed in 2015.

MarkNumberClassesStatusProtected until
Tribitor Z.4635215, 32, 35Protected Nov 4, 2026
ChylOmega (word)Z.4623453, 5Expired –
FITAMINS (word)Z.4591793, 5, 29, 35Expired –
TRInhibitor 3-PHASE CARBOHYDRATE BLOCKER Z.4553845, 32, 35Expired –
TRINHIBITOR (word)Z.4468575, 32, 35Expired –
MarkProtected until
Tribitor Nov 4, 2026
ChylOmega (word)–
FITAMINS (word)–
TRInhibitor 3-PHASE CARBOHYDRATE BLOCKER –
TRINHIBITOR (word)–

Authorized Representatives

Anna Elżbieta Aranowska-Bablok age 46 – Management Board Member
Marek Jan Orłowski age 58 – President of the Management Board

Manner of representation

In the case of a one-person management board, the sole member of the management board is authorised to make declarations of will and sign on behalf of the company, whereas in the case of a multi-member management board, 2 members of the management board acting jointly or 1 member of the management board acting jointly with a commercial proxy are authorised to do so.

Supervisory board

Krzysztof Adam Laskowski age 47 – Supervisory Board Member
Bogusław Andrzej Ulijasz age 53 – Supervisory Board Member
Wojciech Marek Bablok age 46 – Supervisory Board Member
Emil Tomaszewski age 39 – Supervisory Board Member
Giuseppe Schembri – Supervisory Board Member

Beneficial owners

Adiuvo Investments is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Subsidiaries

NameStake
100%
Algaelabs sp. z o.o.
65.8512%

Capital group

The company is the parent company of a corporate group.

NameCountry
Adiuvo ManagementPoland

Bank accounts

Registered as a VAT taxpayer on 2012-08-27.

  • mBank
    98 1140 1010 0000 5412 8400 1006
  • mBank
    55 1140 1010 0000 5412 8400 1004
  • mBank
    87 1140 1010 0000 5412 8400 1010

Debt

3 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Dec 2, 2024
Accelerated arrangement proceedings
Closed
Oct 21, 2024
Petition to open accelerated arrangement proceedings
Closed
Sep 16, 2024
Petition to open accelerated arrangement proceedings
Closed

MSiG notices

Publication dateEvent
Feb 19, 2019Merger registered
Mar 17, 2015Commercial Companies Code notice

Public aid

7 public aid cases recorded, with a total value of $19,325.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$206
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$201
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$206

Competitors

Name
Kvarko Group sp. z o.o.
Aper Ventures S.K.A.
Xevin Investments sp. z o.o.
Unfold.Vc Asi S.A.
Montis Capital S.K.A.
Zorkedo sp. z o.o.
AIP Seed S.A.
Navivo Capital Alternatywna Spółka Inwestycyjna I S.K.A.
Fundingbox Deep Tech Fund S.K.A.
TAR Heel Capital Pathfinder Vc S.K.A.

Change history

DateEvent
2025-02-20Name change
2024-03-26Address change
2020-02-17Address change
2019-05-10Share capital increase
2018-11-08Share capital increase

FAQ

Last updated: 2026-03-24